| Jul 5 |
3 Highly Rated Biotech Stocks for Your July Buy List
|
| Jul 3 |
Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
|
| Jul 3 |
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
|
| Jul 2 |
Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
|
| Jul 2 |
US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
|
| Jul 2 |
Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
|
| Jul 2 |
Biogen Completes Acquisition of Human Immunology Biosciences
|
| Jul 1 |
10 clinical trials to watch in the second half of 2024
|
| Jun 28 |
Biogen, Eisai launch Alzheimer's drug Leqembi in China
|
| Jun 28 |
Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
|
